Calyxo builds the CVAC System, a single-use device targeting kidney stone treatment. The company is early-stage (founded 2016, 201–500 employees) and actively scaling: 44 open roles with 21 posted in the last 30 days signals aggressive hiring across healthcare, engineering, and clinical functions. Stack is standard enterprise (SolidWorks for CAD, NetSuite/Paylocity for ops, Greenhouse for recruiting) with no AI/ML or specialized med-device tooling visible—typical of pre-commercial device companies focused on regulatory validation and supply-chain maturity.
Calyxo is a privately held medical device company founded in 2016 and headquartered in Pleasanton, California. The company develops the CVAC System, a single-use device for kidney stone treatment, addressing a high-volume clinical need with low adoption barriers. The team spans clinical, engineering, healthcare operations, and sales functions, with active projects across device development, regulatory compliance (software design controls, IP), clinical training, and market development (KOL support, roadshow logistics). Key operational challenges include supplier quality management, regulatory compliance, and scaling manufacturing and adoption.
Calyxo develops the CVAC System, a single-use medical device for kidney stone treatment, designed to improve clinical outcomes and reduce healthcare costs in urology.
Calyxo is headquartered in Pleasanton, California and is currently hiring exclusively in the United States.
Other companies in the same industry, closest in size